Among them, ATP and cGAMP activate P2X7 receptor and STING, respectively, in neighboring CD8+ T cells leading to enhanced type I IFN production-mediated immune activation and tumor suppression, especially at early stage (137). This evidence concerns the gene CD8A and neoplasm.